Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 0 | 0 | 8,066 | 56,786 | 14,730 |
| Cost of Goods | N/A | N/A | N/A | N/A | 1,290 |
| Gross Profit | N/A | N/A | 8,066 | 56,786 | 13,440 |
| Operating Expenses | 43,599 | 49,732 | 43,965 | 41,689 | 60,412 |
| Operating Income | -43,599 | -49,732 | -35,899 | 15,097 | -46,682 |
| Other Income | 1,488 | -19 | 398 | 1,363 | 188 |
| Pre-tax Income | -42,111 | -49,751 | -35,501 | 16,460 | -46,494 |
| Income Tax | N/A | -8,821 | -886 | 0 | -238 |
| Net Income Continuous | -42,111 | -40,930 | -34,615 | 16,460 | -46,256 |
| Net Income Discontinuous | N/A | 13,855 | 1,321 | -1,166 | N/A |
| Net Income | $-42,111 | $-27,075 | $-33,294 | $15,294 | $-46,256 |
| EPS Basic Total Ops | -937.72 | -601.82 | -811.76 | 545.84 | -1,777.47 |
| EPS Basic Continuous Ops | -934.67 | -909.73 | -839.75 | 587.82 | -1,777.81 |
| EPS Basic Discontinuous Ops | N/A | 307.91 | 27.99 | -41.99 | N/A |
| EPS Diluted Total Ops | -937.72 | -601.82 | -811.76 | 545.84 | -1,777.47 |
| EPS Diluted Continuous Ops | -934.67 | -909.73 | -839.75 | 587.82 | -1,777.81 |
| EPS Diluted Discontinuous Ops | N/A | 307.91 | 27.99 | -41.99 | N/A |
| EBITDA(a) | $-43,215 | $-48,982 | $-42,925 | $-35,116 | $-56,338 |